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Abstract
Purpose: The principal aim of the review is to study the evidence regarding the effectiveness of diacutaneous Fibrolysis (DF) in musculoskeletal diseases and getting 
some recommendations evidences based. 
Methods: An electronic literature search was conducted utilizing PubMed, ScienceDirect, PEDRO, Cochrane and Mendeley. All titles and abstracts were reviewed, 
and full text articles meeting eligibility criteria were assessed in detail to determine inclusion or exclusion. Articles were reviewed by two different investigators. 
Results: Principal findings of this review shows an improvement in functional capacity and a significant reduction of symptoms in the FD groups, immediately after 
intervention and at least, three months follow up. 
Conclusions: There is limited evidence and more studies are needed to assess the effectiveness of DF to improve the function or the symptomatology.
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Background
Musculoskeletal  diseases  are  one of the main causes of disability 
in the developed world and consume a large amount of health and 
social resources, calculated around 215 billion US$ in US, 26 billion 
Canadian $ in Canada, 38 billion euros in Germany [1], 171,1 million 
US$ in Colombia [2] or 5,7 billion pounds in UK [3]. 
The diacutaneous fibrolysis (FD) technique is a non-invasive 
physiotherapeutic technique which aims to release adherences between 
musculoskeletal system tissues using as a tools a set of hooks. The 
principal aim of the technique is to recover the optimal fascial system 
mobility. 
The clinical use of the fibrolysis diacutaneous to treat musculoskeletal 
diseases is growing and it is achieving really good results. However, the 
scientific evidence is still poor.
Purpose 
The aim of this systematic review is to explore the evidence 
regarding the effectiveness of diacutaneous fibrolysis in musculoskeletal 
diseases and getting some recommendations evidence based.
Methods
An electronic bibliographic search was performed using the next 
databases: PubMed (n = 7), ScienceDirect (n = 8), PEDro (n = 5), 
Cochrane (n =11), Mendeley (n=35). 
The keyword “diacutaneous fibrolysis” was used. The articles found 
in the first search were analysed following the next inclusion criteria: 
published in English language, human subjects, randomized controlled 
trials, an intervention group treated by FD, patients suffering a muscu-
loskeletal disease.
Using the PEDro scale, two different investigators analysed the 
quality of methodology in articles found in our research to be accepted 
in our inclusion criteria.
Results
The first search yielded 66 articles but only 4 satisfied the inclusion 
criteria after the first reading [4-7]. The studies selected had a 
methodological average score of 9 in PEDro scale (scale range 0-11, 
best possible score was 11). 
All these 4 studies included in our revision demonstrated a clear 
improvement in functional capacity in the FD groups immediately 
after intervention. Moreover, the improvement lasted three months’ 
follow-up in two studies (one of the others two didn’t assess the mid-
term follow-up). 
Two articles demonstrated significant reduction of symptoms in 
the FD group. The other two didn’t find this symptoms release.
Conclusion
There’s limited evidence showing the symptom improvement us-
ing DF immediately after the intervention compared to conventional 
or placebo treatment.
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More studies are needed in the assessment of DF effectiveness 
to improve functionality or symptomatic conditions to draw firm 
conclusions, especially long-term reviews. Furthermore, studies should 
focus on specific injuries to draw more particular conclusions about the 
use of FD in that injury.
Implications
We recommend fibrolysis diacutaneous, compared to control or 
placebo, for improving functional capacity and symptom conditions in 
patients suffering musculoskeletal diseases. 
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